Concepedia

Publication | Closed Access

Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes

DOI

65

Citations

19

References

2019

Year

Adrían V. Hernández, G. Bradley, Mohammad Khan, Andrew J Fratoni, Anna Gasparini, Yuani M. Roman, Thomas J. Bunz, Daniel Eriksson, Anna‐Katharina Meinecke, Craig I Coleman
European Heart Journal - Quality of Care and Clinical Outcomes

Abstract

Rivaroxaban appears to be associated with lower risks of undesirable renal outcomes vs. warfarin in diabetic NVAF patients.

References

YearCitations

Page 1